GlassScriptPhysician profile
Steven S Blanken
NPI 1194704023
$4,893.59
in general payments reported to CMS, 2019-2025
36 companies · $828 in 2025
The $828 reported for 2025 was more than what 76% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $637 · 2020: $172 · 2021: $239 · 2022: $461 · 2023: $1,032 · 2024: $1,525 · 2025: $828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,557 · Travel and Lodging: $549 · Gift: $147 · Entertainment: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,556.94 |
| Travel and Lodging | $548.62 |
| Gift | $147.27 |
| Entertainment | $132.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $624.89 | 2024 | |
| Convatec INC. | $523.66 | 2023-2025 | |
| Smith+Nephew, INC. | $350.04 | 2020-2025 | Grafix Pl, Oasis Micro, Stravix Mesh |
| Vaporox, INC. | $314.14 | 2023 | Vht-200 Wound Treatment System |
| Bioventus LLC | $265.95 | 2022-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Medtronic, INC. | $239.41 | 2023-2025 | Inceptiv, Closurefast |
| Paratek Pharmaceuticals, INC. | $235.99 | 2021-2024 | Nuzyra |
| Supreme Orthopedic Systems, LLC | $235.38 | 2024 | |
| Horizon Therapeutics Plc | $206.96 | 2019-2023 | Krystexxa |
| Nevro Corp. | $197.97 | 2022-2023 | Senza |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $175.52 | 2019-2025 | Jublia |
| Triad Life Sciences INC. | $161.17 | 2022 | |
| Globus Medical, INC. | $152.41 | 2025 | Senza |
| Nuo Therapeutics | $132.15 | 2025 | |
| Melinta Therapeutics, LLC | $124.97 | 2019 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $106.69 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Merck Sharp & Dohme LLC | $94.49 | 2019 | |
| Treace Medical Concepts, INC. | $94.04 | 2024 | |
| Curonix LLC | $87.27 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Osiris Therapeutics INC. | $80.79 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $78.11 | 2019 | |
| Sebela Pharmaceuticals INC. | $75.97 | 2019-2022 | |
| Organogenesis INC. | $67.49 | 2021-2022 | |
| Linvatec Corporation | $40.39 | 2023 | Biobrace 23mm |
| Ani Pharmaceuticals, INC. | $30.46 | 2025 | Purified Cortrophin Gel |
| Averitas Pharma INC. | $26.91 | 2024 | Qutenza |
| Pacira Pharmaceuticals Incorporated | $25.57 | 2024 | Exparel, Iovera |
| Acumed LLC | $24.96 | 2024 | Acumed, Osteomed |
| Progenacare Global, LLC | $21.17 | 2024 | |
| Trice Medical, INC. | $21.03 | 2025 | |
| Acell, INC. | $16.21 | 2020 | |
| Abbott Laboratories | $15.08 | 2020 | |
| Aroa Biosurgery Incorporated | $14.07 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.01 | 2022 | |
| Tactile Systems Technology INC | $11.95 | 2020 | |
| Medela LLC | $8.32 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Blanken listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.